These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21455100)

  • 1. Activated and inactivated PPARs-γ modulate experimentally induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Slomka M; Radej S; Cichoz-Lach H; Madro A
    Med Sci Monit; 2011 Apr; 17(4):BR116-24. PubMed ID: 21455100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis.
    Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Slomka M
    J Physiol Pharmacol; 2012 Dec; 63(6):631-40. PubMed ID: 23388479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
    J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
    Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A
    Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
    Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis.
    Li XL; Cai YQ; Qin H; Wu YJ
    Can J Physiol Pharmacol; 2008 Dec; 86(12):841-9. PubMed ID: 19088805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis.
    Eliakim R; Karmeli F; Rachmilewitz D; Cohen P; Fich A
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1013-9. PubMed ID: 9895047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
    Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
    J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
    Shah YM; Morimura K; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
    Berruyer C; Pouyet L; Millet V; Martin FM; LeGoffic A; Canonici A; Garcia S; Bagnis C; Naquet P; Galland F
    J Exp Med; 2006 Dec; 203(13):2817-27. PubMed ID: 17145956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
    Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
    J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways.
    Tang X; Huang G; Zhang T; Li S
    Biosci Biotechnol Biochem; 2020 Sep; 84(9):1903-1912. PubMed ID: 32525764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.